IGI Laboratories, Inc. Announces 4th Quarter 2012 and Year End 2012 Results
I Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the fourth quarter and year ended December 31, 2012.
Fourth Quarter 2012 Highlights vs. 2011
• Total Revenues of $2.3 million, increase of 10% over same quarter in 2011
• Invested in the infrastructure of our commercialization strategy and successfully launched the first ever IGI label generic topical pharmaceutical products
Fourth Quarter 2012 Highlights vs. 2011
• Total Revenues of $2.3 million, increase of 10% over same quarter in 2011
• Invested in the infrastructure of our commercialization strategy and successfully launched the first ever IGI label generic topical pharmaceutical products